Globus Medical Announces $500 Million Share Repurchase Program

Core Viewpoint - Globus Medical, Inc. has authorized a share repurchase program of up to $500 million to address the disconnect between its intrinsic value and market valuation, reflecting confidence in its long-term growth and profitability [1][2]. Group 1: Share Repurchase Program - The share repurchase program is aimed at buying back up to $500 million of the company's outstanding common stock [1]. - The timing and number of shares repurchased will be at management's discretion, influenced by market conditions and other factors [2]. - The program will be funded using the company's cash reserves and aligns with its long-term capital allocation strategy [3]. Group 2: Company Overview - Globus Medical is a leading global musculoskeletal solutions company focused on addressing unmet clinical needs and improving patient outcomes [4]. - The company emphasizes innovation, education, and clinical support across various areas including spine, orthopedic trauma, and joint reconstruction [4].